Suppliers / Ravi Biolife

Ravi Biolife

India 29 employees Updated 9 July 2026

Ravi Biolife is an API manufacturer based in India. It holds 3 active US drug master files and 4 valid CEPs across a filed portfolio of 5 molecules. Its filings concentrate with EEC_EAEU and MINSA (CR). Customs aggregates show $180K of exports covering 32 molecules to 9 destinations in 2025.

3
active US DMFs
4
valid CEPs
3
registered plants 1 with an FDA FEI number
4
filings across 2 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026.

Registered plants

Site FDA FEI
Mumbai, India Not on file
Raigad, India 3027545288
Mumbai, India Not on file

What they file, and where

Molecule Regulators Docs
Gemcitabine EDQM, US FDA 2
Methotrexate EDQM, US FDA 2
Nilotinib EDQM 1
Pemetrexed US FDA 1
Pemetrexed Disodium EDQM 1

Also appears on these molecule pages

Gemcitabine API Methotrexate API Nilotinib API Pemetrexed API Pemetrexed Disodium API

Filings and GMP by regulator

Regulator Filings GMP certificates
EEC_EAEU 3 None
MINSA (CR) 1 None

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $47K 3
2025 Not reported $180K 9
2024 Not reported $58K 4
2023 Not reported $2K 1

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Ravi Biolife

Does Ravi Biolife hold a US DMF or a CEP?
Ravi Biolife holds 3 active US drug master files and 4 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Ravi Biolife FDA-registered?
One site operated by Ravi Biolife carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
Where does Ravi Biolife manufacture?
3 registered sites are on record, in India (Mumbai and Raigad among others). Every site is listed on this page with the register it came from.
What does Ravi Biolife make?
5 molecules are on record against Ravi Biolife, including Gemcitabine, Methotrexate, Nilotinib and Pemetrexed. Each links through to that molecule's full manufacturer list.
Where does Ravi Biolife file?
Filings are on record with EEC (Eurasian Economic Union) and MINSA (CR), 4 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Ravi Biolife comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

MSN Laboratories shares 5 molecules Hetero shares 4 molecules Dr Reddy's Laboratories shares 4 molecules Shilpa Pharma Lifesciences shares 4 molecules Jiangsu Hansoh Pharmaceutical Group shares 3 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts